{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:33:22Z","timestamp":1787841202882,"version":"build-2784847793"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Anti-tuberculosis (TB) drugs are a common cause of hepatotoxicity. Hepatoprotective agents are often empirically used to prevent anti-TB drug-induced hepatitis (DIH). This study aimed to evaluate the incidence of DIH in new TB patients receiving hepatoprotective agents and identify associated risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A retrospective cross-sectional study was conducted on 140 new pulmonary TB patients at two hospitals in Makassar, Indonesia. The diagnosis of TB and DIH severity (based on World Health Organization criteria) was determined by pulmonologists. Data on demographics, comorbidities, time to DIH onset, liver enzyme levels such aspartate aminotransferase (AST), alanine aminotransferase (ALT), and bilirubin were analyzed using Chi-square and paired\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -tests.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      DIH was observed in 38 (27.1%) patients. It was more prevalent in females and individuals over 50 years. The majority of DIH cases were grade two, characterized by elevated AST (71.1%) and ALT (47.7%). Comorbidities, including diabetes mellitus (28.9%), human immunodeficiency virus (10.5%), and chronic kidney disease (2.6%), were significantly associated with a higher incidence of DIH (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). The mean onset of DIH was within 14 days in 94.7% of cases. While AST and ALT significantly increased posttreatment (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), bilirubin levels did not correlate with these increases. The administration of hepatoprotective agents was associated with a 73% reduction in DIH incidence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Despite the use of hepatoprotective agents, advanced age and the presence of comorbidities significantly increase the risk of DIH in TB patients undergoing anti-TB treatment. These findings highlight the importance of careful monitoring and management of high-risk TB patients, even with hepatoprotective co-administration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijmy.ijmy_67_25","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T19:00:15Z","timestamp":1757962815000},"page":"219-225","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The Effect of Hepatoprotectors on the Risk of Drug-induced Hepatitis in Pulmonary Tuberculosis Patients"],"prefix":"10.4103","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8401-6438","authenticated-orcid":false,"given":"Eko Indra","family":"Noviansyah","sequence":"first","affiliation":[{"name":"Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Dr. Wahidin Sudirohusodo Hospital and Hasanuddin University Hospital, Hasanuddin University, Makassar, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irawaty","family":"Djaharuddin","sequence":"additional","affiliation":[{"name":"Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Dr. Wahidin Sudirohusodo Hospital, Hasanuddin University, Makassar, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry Akza","family":"Putrawan","sequence":"additional","affiliation":[{"name":"Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Dr. Wahidin Sudirohusodo Hospital, Hasanuddin University, Makassar, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamaluddin","family":"Madolangan","sequence":"additional","affiliation":[{"name":"Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Labuang Baji Hospital, Hasanuddin University, Makassar, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulkis","family":"Natsir","sequence":"additional","affiliation":[{"name":"Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Batara Siang Hospital, Hasanuddin University, Makassar, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Pandu","sequence":"additional","affiliation":[{"name":"Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Ibnu Sina Hospital, Hasanuddin University, Makassar, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"R1-20250915","doi-asserted-by":"crossref","first-page":"100556","DOI":"10.1016\/j.ijregi.2024.100556","article-title":"Advancing tuberculosis elimination in India: A qualitative review of current strategies and areas for improvement in tuberculosis preventive treatment","volume":"14","author":"Shah","year":"2025","journal-title":"IJID Reg"},{"key":"R2-20250915","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1186\/s12889-024-20664-w","article-title":"Global, regional, and national burden of tuberculosis and attributable risk factors for 204 countries and territories, 1990-2021: A systematic analysis for the Global Burden of Diseases 2021 study","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Public Health"},{"key":"R3-20250915","doi-asserted-by":"crossref","first-page":"464","DOI":"10.5530\/pj.2022.14.59","article-title":"Virgin coconut oil and tuberculosis: A mini-review","volume":"14","author":"Djannah","year":"2022","journal-title":"Pharmacogn J"},{"key":"R4-20250915","doi-asserted-by":"crossref","first-page":"108143","DOI":"10.1016\/j.ijscr.2023.108143","article-title":"A rare case of femoral artery saccular aneurysm caused by tuberculosis in a male patient: A case report and review of literature","volume":"106","author":"Mulawardi","year":"2023","journal-title":"Int J Surg Case Rep"},{"key":"R5-20250915","first-page":"1","article-title":"Anti-Tuberculosis Drug-Induced Hepatotoxicity and Associated Risk Factors Among Pulmonary Tuberculosis Patients at a Tertiary Care Hospital in Thailand","volume":"15","author":"Mukura","year":"2025","journal-title":"IJID Reg"},{"key":"R6-20250915","doi-asserted-by":"crossref","first-page":"e0236109","DOI":"10.1371\/journal.pone.0236109","article-title":"The high incidence of severe adverse events due to pyrazinamide in elderly patients with tuberculosis","volume":"15","author":"Kwon","year":"2020","journal-title":"PLoS One"},{"key":"R7-20250915","doi-asserted-by":"crossref","first-page":"44","DOI":"10.20956\/nmsj.v5i1.13450","article-title":"Case Reports on Severe Antituberculosis-Drug Induced Hepatotoxicity in Tuberculosis Patients: The Post-Incidence Therapy","volume":"5","author":"Basir","year":"2021","journal-title":"Nusant Med Sci J"},{"key":"R8-20250915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/4044530","article-title":"Investigating the relationship between knowledge and hepatotoxic effects with medication adherence of TB patients in banyumas regency, Indonesia","volume":"2022","author":"Perwitasari","year":"2022","journal-title":"Int J Clin Pract"},{"key":"R9-20250915","doi-asserted-by":"crossref","first-page":"107230","DOI":"10.1016\/j.ijid.2024.107230","article-title":"Assessing hepatotoxicity in novel and standard short regimens for rifampicin-resistant tuberculosis: Insights from the TB-TRUST and TB-TRUST-plus trials","volume":"148","author":"Song","year":"2024","journal-title":"Int J Infect Dis"},{"key":"R10-20250915","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5530\/ijopp.15.2.25","article-title":"Antituberculosis drug induced hepatitis: A case-report","volume":"15","author":"Shah","year":"2022","journal-title":"Indian J Pharm Pract"},{"key":"R11-20250915","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/liv.14896","article-title":"Incidence and risk factors of anti-tuberculosis drug induced liver injury (DILI): Large cohort study involving 4652 Chinese adult tuberculosis patients","volume":"41","author":"Jiang","year":"2021","journal-title":"Liver Int"},{"key":"R12-20250915","doi-asserted-by":"crossref","first-page":"49","DOI":"10.20473\/jr.v6-I.2.2020.49-54","article-title":"Tuberculosis drug-induced liver injury","volume":"6","author":"Soedarsono","year":"2020","journal-title":"J Respirasi"},{"key":"R13-20250915","first-page":"1857","article-title":"The hepatoprotective effect of Marchantia paleacea bertol. extract against acetaminophen-induced liver damage in rat: Biochemical and histological evidence","volume":"26","author":"Bakhtiar","year":"2022","journal-title":"J Res Pharm"},{"key":"R14-20250915","doi-asserted-by":"crossref","first-page":"706","DOI":"10.5530\/pres.16.4.82","article-title":"Exploring the mechanisms and dosages of herbal hepatoprotective agents","volume":"16","author":"Rajappa","year":"2024","journal-title":"Pharmacogn Res"},{"key":"R15-20250915","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s43066-023-00248-w","article-title":"Promising hepatoprotective agents from the natural sources: A study of scientific evidence","volume":"13","author":"Pandey","year":"2023","journal-title":"Egypt Liver J"},{"key":"R16-20250915","first-page":"25","article-title":"Determination of sample size and sampling methods in applied research","volume":"3","author":"Nanjundeswaraswamy","year":"2021","journal-title":"Proc Eng Sci"},{"key":"R17-20250915","doi-asserted-by":"crossref","first-page":"113","DOI":"10.11604\/pamj.2024.49.113.45645","article-title":"Factors associated with Leptospira serodiagnosis in febrile patients at public health centers in Makassar, Indonesia: A cross-sectional study","volume":"49","author":"Cahyaningtyas","year":"2024","journal-title":"Pan Afr Med J"},{"key":"R19-20250915","doi-asserted-by":"crossref","first-page":"122","DOI":"10.34172\/aim.2024.19","article-title":"Managing hepatotoxicity caused by anti-tuberculosis drugs: A comparative study of approaches","volume":"27","author":"Abbaspour","year":"2024","journal-title":"Arch Iran Med"},{"key":"R20-20250915","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40264-023-01390-5","article-title":"Drug-induced liver injury in the elderly: Consensus statements and recommendations from the IQ-DILI initiative","volume":"47","author":"Cohen","year":"2024","journal-title":"Drug Saf"},{"key":"R21-20250915","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MOG.0000000000000526","article-title":"Tools for causality assessment in drug-induced liver disease","volume":"35","author":"Tillmann","year":"2019","journal-title":"Curr Opin Gastroenterol"},{"key":"R22-20250915","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12664-024-01674-3","article-title":"Drug-induced liver injury due to first-line antituberculosis medications in India: A major hindrance to achieve the goal of tuberculosis elimination","volume":"44","author":"Gopalakrishna","year":"2025","journal-title":"Indian J Gastroenterol"},{"key":"R23-20250915","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5582\/ddt.2020.03029","article-title":"Malnutrition as an important risk factor for drug-induced liver injury in patients on anti-tubercular therapy: An experience from a tertiary care center in South India","volume":"14","author":"Ali","year":"2020","journal-title":"Drug Discov Ther"},{"key":"R24-20250915","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13104-019-4872-1","article-title":"Drug-induced hepatotoxicity among TB\/HIV co-infected patients in a referral hospital, Ethiopia","volume":"13","author":"Zeleke","year":"2020","journal-title":"BMC Res Notes"},{"key":"R25-20250915","doi-asserted-by":"crossref","first-page":"ofad422","DOI":"10.1093\/ofid\/ofad422","article-title":"Metabolic disorders are associated with drug-induced liver injury during antituberculosis treatment: A multicenter prospective observational cohort study in Korea","volume":"10","author":"Lim","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"R26-20250915","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/liv.15262","article-title":"Incidence and risk factors of drug-induced liver injury","volume":"42","author":"Li","year":"2022","journal-title":"Liver Int"},{"key":"R27-20250915","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.imj.2022.07.003","article-title":"Hepatoprotective drugs for prevention of liver injury resulting from anti-tuberculosis treatment: A meta-analysis of cohort studies","volume":"1","author":"Wang","year":"2022","journal-title":"Infect Med (Beijing)"},{"key":"R28-20250915","first-page":"37","article-title":"Associated with Anti-tuberculosis Therapy in Patients with Tuberculosis and TB-HIV Co-infection","volume":"9","author":"Azmi","year":"2022","journal-title":"Med Hosp J Clin Med"},{"key":"R29-20250915","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/pathogens9110950","article-title":"Increased prevalence of liver fibrosis and HIV viremia among patients with HIV, HBV, and tuberculosis in Botswana","volume":"9","author":"Phinius","year":"2020","journal-title":"Pathogens"},{"key":"R30-20250915","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.53730\/ijhs.v6nS7.11749","article-title":"Prevalence of tuberculosis among HIV positive patients on anti-retroviral therapy with special emphasis on pattern of adverse events of first-line anti-tubercular drug","volume":"6","author":"Banjare","year":"2022","journal-title":"Int J Health Sci"},{"key":"R32-20250915","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.jceh.2023.07.090","article-title":"A comparative study on drug induced hepatotoxicity among HIV infected and HIV noninfected cases of newly diagnosed tuberculosis","volume":"13","author":"Mukherjee","year":"2023","journal-title":"J Clin Exp Hepatol"},{"key":"R33-20250915","doi-asserted-by":"crossref","first-page":"399","DOI":"10.18203\/2349-3933.ijam20220776","article-title":"Clinical characteristics, serum albumin and eosinophil levels as risk factors for drug induced hepatitis in tuberculosis patients receiving fixed-dose combination anti-tuberculosis drug","volume":"9","author":"Anastasia","year":"2022","journal-title":"Int J Adv Med"},{"key":"R34-20250915","doi-asserted-by":"crossref","first-page":"e0286306","DOI":"10.1371\/journal.pone.0286306","article-title":"Does diabetes mellitus comorbidity increase the risk of drug-induced liver injury during tuberculosis treatment?","volume":"18","author":"Freire","year":"2023","journal-title":"PLoS One"},{"key":"R35-20250915","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat Rev Dis Primer"},{"key":"R36-20250915","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMra1816149","article-title":"Drug-induced liver injury \u2013 Types and phenotypes","volume":"381","author":"Hoofnagle","year":"2019","journal-title":"N Engl J Med"},{"key":"R37-20250915","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamainternmed.2024.1836","article-title":"Severe acute liver injury after hepatotoxic medication initiation in real-world data","volume":"184","author":"Torgersen","year":"2024","journal-title":"JAMA Intern Med"},{"key":"R38-20250915","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/hep.32689","article-title":"AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury","volume":"77","author":"Fontana","year":"2023","journal-title":"Hepatol Baltim Md"},{"key":"R39-20250915","doi-asserted-by":"crossref","first-page":"155142","DOI":"10.1016\/j.phymed.2023.155142","article-title":"Drug-induced liver injury and anti-hepatotoxic effect of herbal compounds: A metabolic mechanism perspective","volume":"122","author":"Rani","year":"2024","journal-title":"Phytomedicine"},{"key":"R40-20250915","doi-asserted-by":"crossref","first-page":"101875","DOI":"10.5409\/wjcp.v14.i2.101875","article-title":"Understanding antituberculosis drug-induced hepatotoxicity: Risk factors and effective management strategies in the pediatric population","volume":"14","author":"Semwal","year":"2025","journal-title":"World J Clin Pediatr"},{"key":"R41-20250915","doi-asserted-by":"crossref","first-page":"321","DOI":"10.54817\/IC.v65n3a05","article-title":"Protective effects of thiamine pyrophosphate and cinnamon against oxidative liver damage induced by an isoniazid and rifampicin combination in rats","volume":"65","author":"Yeter","year":"2024","journal-title":"Investig Cl\u00edn"},{"key":"R42-20250915","doi-asserted-by":"crossref","first-page":"48","DOI":"10.15407\/ubj96.03.048","article-title":"Embelin mitigates hepatotoxicity induced by isoniazid and rifampicin in rats","volume":"96","author":"Mosa","year":"2024","journal-title":"Ukr Biochem J"},{"key":"R43-20250915","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/10937404.2023.2261848","article-title":"Drug induced liver injury \u2013 A 2023 update","volume":"26","author":"Allison","year":"2023","journal-title":"J Toxicol Environ Health B Crit Rev"}],"container-title":["The International Journal of Mycobacteriology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_67_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:43:13Z","timestamp":1787838193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_67_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmy.ijmy_67_25","relation":{},"ISSN":["2212-5531","2212-554X"],"issn-type":[{"value":"2212-5531","type":"print"},{"value":"2212-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2025-05-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}